B3 Holding — Full Portfolio
16 tracked investments · listed companies and verified rows first
Ginkgo Bioworks builds autonomous labs and offers cell-programming and bioengineering services for the biopharma, agriculture, and industrial biotech markets.
AgTechAI & Machine LearningBiotechDeep TechHealthtechBoston, US
Jason Kelly(Founder)inAustin Che(Founder)inTom Knight(Founder)inBarry Canton(Founder)inReshma Shetty(Founder)in
BoardReshma Sohoni
Co-investors11.2 CapitalCannage CapitalCool Climate CollectiveDCVC (Data Collective)Designer FundDraper Associates+15 more
Wood pellet producer in Belarus supplying renewable feedstock across the EU.
DIANA Biotechnologies develops PCR and RT-PCR reagents, custom oligonucleotide synthesis, monoclonal antibodies, ultrasensitive sepsis diagnostics, and kinase inhibitor profiling services for diagnostic and academic laboratories.
BiotechHealthtechMedical Devices
Martin Dienstbier(Co-CEO)
Co-investorsBiotech Investments S.R.O
Draslovka is a Czech family-owned chemicals company that develops and produces cyanide (CN) family chemical products and applications.
CleantechNew Materials
Platform enabling scientists to work with microbiome data.
Co-investorsFuture Planet Capital
Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.
BiotechHealthtechMedical DevicesSomerville, US
Mark Smith(Executive Officer, Director)Matt Blischak(Chief Executive Officer)R. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)
Co-investorsOctave Ventures LlcOCV PartnersOMX VenturesShumway CapitalHumboldt
Groundwork BioAg produces mycorrhizal fungi inoculants (marketed as Rootella) for farmers, using the fungi's carbon pathway into soil to enable large-scale, verifiable carbon sequestration while improving crop productivity, soil fertility, and reducing fertilizer use.
AgTechBiotechClimate TechImpact & Social Good
Co-investorsClimate Innovation CapitalMiddleland CapitalBridges Fund Management Ltd.MoreVC
Hexagon Bio develops novel payload mechanisms for antibody-drug conjugates (ADCs) aimed at overcoming resistance to current cancer treatments and expanding ADC indications.
BiotechDeep TechHealthtechMenlo Park, US
Colin James Bell Harvey(Director)Brian T. Naughton(Director)Maureen E. Hillenmeyer(Executive Officer, Director)Maureen Hillenmeyer(CEO & Co-Founder)in
BoardAlex Kolich(Director)
Co-investorsNextech InvestSoftBank Vision FundThe Column Group8VCCasdin CapitalTwo Sigma Ventures
Developer of small-molecule antivirulence agents against bacterial infections.
Sampling Human builds production systems that generate cellular-resolution data from clinical samples to support diagnostics, health products, and AI models operating on individual patient biology.
AI & Machine LearningBiotechHealthtech
Co-investorsBiotech Investments S.R.O
SCase Vital is a certified class IIb all-in-one medical device that measures vital signs such as body temperature, blood pressure, pulse, blood oxygen and glucose, records wound photos, and transfers data to clinical information systems.
Digital HealthHardwareMedical DevicesPrague, CZ
Precision-medicine platform predicting which therapy a patient will respond to based on disease biology.
Scipher Medicine is a precision immunology company that uses molecular blood tests, such as PrismRA, to match patients with the most effective therapy for autoimmune diseases like rheumatoid arthritis.
AI & Machine LearningBiotechDigital Health
Joseph Loscalzo(Founder | Physician-in-Chief, Brigham and Women's Hospital)Albert-László Barabási(Founder | Professor, Harvard and Northeastern University)
Co-investorsaMoonKhosla VenturesCobalt VenturesEcho Health VenturesHitachi VenturesOptum Ventures+1 more
Microbiome analysis company using lab science and machine learning to identify markers and interventions.
BiotechSan Francisco, US
John S. Eid, Ph.D.(Executive Officer, Director)Colleen Cutliffe(Executive Officer, Director)James H. Bullard, Ph.D.(Executive Officer)Orville Kolterman, M.D.(Executive Officer)
BoardAdam D'Augelli(Director)Peter Barton Hutt(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
